Kadans Science Partner (“Kadans”), a leading European investor in the development of ecosystems and real estate with a dedicated focus on knowledge-intensive sectors, has commenced construction on its purpose-built laboratory facility, Versa.
As the second project to be delivered by Kadans within the Tileyard Quarter in King’s Cross, London, this is a significant milestone for both the area and London’s life science sector more generally.
Due to complete in Q2 2026, and located at 4 Brandon Road, Versa will provide 51,500 sq ft of space, designed to accommodate a range of uses from CL2 labs…
Miltenyi Biotec, an innovator of products and services for biomedical research and cell and gene therapies, has announced a strategic partnership with leading developer of life science ecosystems, integrating infrastructure, investment, and venture support, Pioneer Group.
Through this collaboration, Miltenyi Biotec will establish a suite of state-of-the-art instruments at Victoria House, Pioneer’s flagship life sciences centre in London’s Knowledge Quarter. This strategic placement will empower Miltenyi Biotec to accelerate research and development while directly engaging with the site’s…
Read April eNews here 👉 https://shorturl.at/xZ6e9Sponsored by Catalent Pharma Solutions
Featuring:
✅ Reporting on a Month of Support, Celebration and Insights, by Tony Jones, CEO, One Nucleus✅ Logistically Thinking When It Comes To Value Creation with Tushar Madani and Michael O'Kane from CoolReach Healthcare Logistics LTD✅ Global R&D Tax Incentives for SMEs: A Cross-country Comparison by RSM✅ Life Science Financing Summary - Review of February 2025 Data from Venture Valuation AG✅ Why You Should Use a Travel Management Company for Your Next Trip by Romy Frow, Travel Counsellors✅ How…
London, April 1, 2025 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, is delighted to announce the strengthening of its management team with the promotion of Penny Sadler as Managing Partner.Penny Sadler brings 30 years of global search experience to her new role, with a specialization in medtech, diagnostics, and life sciences tools. She also possesses deep expertise in Benelux pharmaceuticals, as well as biotech startups and scaleups. As head of Coulter Partners’ Belgium office, she has demonstrated exceptional…
Are you a pre-clinical therapeutics start-up?
Stevenage Bioscience Catalyst’s Catalyser is an accelerator designed to help businesses attract investors and partners, and maximise overall chances of commercial success.
The Triple Chasm framework is used to structure the programme via six interactive sessions on the below topics:
• Market Space Definition
• Proposition Framing
• Customer Definition
• Contingent Technology Management
• IP Management
• Product Synthesis
• Human Capital
• Funding Strategy
• Strategic Positioning
Complimentary CRO services package:
Businesses that take part will…
Read the March edition of our People Pathways newsletter here.
Featuring:
✅One Nucleus upcoming courses✅South Carolina visit✅Apprentice opportunity from Domainex✅Industry news and more...
Oh what a night!
A fantastic array of life science innovators met up at the One Nucleus Annual Awards Dinner in London last night to celebrate their incredible achievements.
Many congratulations to the winners and finalists:
Best Performing Therapeutic Discovery Company of the YearWinner: AviadoBioFinalists: Healx, Resolution Therapeutics
Best Performing R&D Platform Development Company of the YearWinner: Constructive BioFinalists: Nuclera, OutSee
Best Performing New Company Creator of the YearWinner: UCL Business LtdFinalists: Deep Science Ventures, Babraham Research Campus
Best…
Discovery Park has successfully concluded its latest Discovery Spark programme, an intensive business growth catalyst supporting early-stage start-ups. Designed to assist innovators refine their commercial strategies, build investor readiness, and connect with likeminded peers and industry specialists, the programme culminated in pitches from 10 pioneering companies dedicated to improving cancer treatment and patient outcomes.
This oncology-themed cohort, supported by Capital Enterprise Network, CRUK, NHS Kent & Medway Cancer Alliance, and the University of Kent, brought together…
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease that is marked by synovial inflammation, joint destruction, and systemic complication. Aside from causing great physical distress, RA also significantly adds to the socioeconomic burden posed on society. Because of the complex nature of its pathogenesis and the lack of specific symptoms in the initial stages of the disease, early diagnosis and intervention are very important to prevent severe disease progression.The diagnosis of RA typically relies on a comprehensive assessment of clinical manifestations, imaging techniques,…
iBoxit, a company based at Norwich Research Park, has been named as the winner of the Business Innovation Award at the Broadland and South Norfolk Business Awards 2025. iBoxit is a collaboration between entrepreneur John Farley and the University of East Anglia (UEA) under the tutelage of Prof Sheng Qi.
iBoxit is leading the charge to tackle the environmental impact of expanded polystyrene. Through its innovative development of a new, environmentally-sustainable packaging that uses an intricate mixture of existing plastic and plant-based composite to replace the expanded polystyrene boxes…